Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1156255

registered interest
date	24/10/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Imperial College Healthcare NHS Trust: Finance
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how much of the seed funding announced on 30 September 2019 will be allocated to (a) Charing Cross Hospital, (b) Hammersmith Hospital and (c) St Mary's Hospital, Paddington.
tabling member constituency	Hammersmith
tabling member printed	Andy Slaughter
uin	4953
answer	answer is ministerial correction date of answer 29/10/2019 answer text <p>As announced on 30 September £100 million of seed funding has been made available to support 21 major projects to commence their development of schemes to be delivered in a second phase of major hospital rebuilds (HIP2).</p><p>This £100 million of seed funding will be provided as capital and will enable project teams, specialist advisers and site surveys. The funding will be drawn by providers in line with need up to 1% of the estimated capital value of each HIP2 scheme. The budget has been received for 2020-21 and 2021-22 financial years but funding this year could be available if there is an immediate and strong case. NHS England and NHS Improvement will be visiting the schemes to discuss their proposals and how they can be helped to develop.</p><p>Trusts will be required to provide a breakdown of what seed funding will be spent on and how that will accelerate the project development. The Department and NHS England and NHS Improvement will then ascertain how much seed funding will be provided for each scheme.</p><p>Seed funding will not constitute approval of the scheme as a whole as that will be subject to further development and subject to the usual business case approvals process, including demonstrating affordability and value for money.</p><p> </p> answering member constituency Charnwood answering member printed Edward Argar grouped question UIN 4954 question first answered 29/10/2019 14:48:34 answering member 4362 label Biography information for Edward Argar
tabling member	1516 label Biography information for Andy Slaughter

1156256

registered interest
date	24/10/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Hospitals: Construction
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, when the seed funding announced on 30 September 2019 will be allocated to Hospital Trusts; and what conditions will be attached to the use of that funding.
tabling member constituency	Hammersmith
tabling member printed	Andy Slaughter
uin	4954
answer	answer is ministerial correction date of answer 29/10/2019 answer text <p>As announced on 30 September £100 million of seed funding has been made available to support 21 major projects to commence their development of schemes to be delivered in a second phase of major hospital rebuilds (HIP2).</p><p>This £100 million of seed funding will be provided as capital and will enable project teams, specialist advisers and site surveys. The funding will be drawn by providers in line with need up to 1% of the estimated capital value of each HIP2 scheme. The budget has been received for 2020-21 and 2021-22 financial years but funding this year could be available if there is an immediate and strong case. NHS England and NHS Improvement will be visiting the schemes to discuss their proposals and how they can be helped to develop.</p><p>Trusts will be required to provide a breakdown of what seed funding will be spent on and how that will accelerate the project development. The Department and NHS England and NHS Improvement will then ascertain how much seed funding will be provided for each scheme.</p><p>Seed funding will not constitute approval of the scheme as a whole as that will be subject to further development and subject to the usual business case approvals process, including demonstrating affordability and value for money.</p><p> </p> answering member constituency Charnwood answering member printed Edward Argar grouped question UIN 4953 question first answered 29/10/2019 14:48:34 answering member 4362 label Biography information for Edward Argar
tabling member	1516 label Biography information for Andy Slaughter

1125271

registered interest
date	08/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Chronic Obstructive Pulmonary Disease: Death
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many deaths were caused by Chronic obstructive pulmonary disease in affected areas in England during the air pollution episode in April 2019; and what comparative assessment he has made of the figures for that period with (a) expected average and (b) average over the last five years.
tabling member constituency	Hammersmith
tabling member printed	Andy Slaughter
uin	251937
answer	answer is ministerial correction date of answer 13/05/2019 answer text <p>According to the Daily Air Quality Index (DAQI) there were ‘moderate’ to ‘very high’ levels of air pollution in some areas of the United Kingdom between 7 and 8 April and between 15 to 25 April 2019. The figures for deaths caused by chronic obstructive pulmonary disease in this period are not available in the requested format and a comparative assessment has not been made.</p><p>In January 2019 the Government launched the Clean Air Strategy, which sets out plans for dealing with all sources of air pollution to save lives, protect nature and boost the economy.</p><p> </p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 13/05/2019 15:46:29 answering member 4455 label Biography information for Seema Kennedy
tabling member	1516 label Biography information for Andy Slaughter

1125272

registered interest
date	08/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Strokes: Death
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many deaths caused by stroke there were in affected areas in England during the pollution episode in April 2019; and what comparative assessment he has made of the number of deaths attributed to stroke in that period with the (a) expected average and (b) average over the last five years.
tabling member constituency	Hammersmith
tabling member printed	Andy Slaughter
uin	251938
answer	answer is ministerial correction date of answer 17/05/2019 answer text <p>According to the Daily Air Quality Index there were ‘moderate’ to ‘very high’ levels of air pollution in some areas of the United Kingdom between 7 and 8 April and between 15 to 25 April 2019. The figures for deaths caused by stroke in this period are not available in the requested format and a comparative assessment has not been made.</p><p>In January 2019, the Government launched the Clean Air Strategy, which sets out plans for dealing with all sources of air pollution to save lives, protect nature and boost the economy.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 17/05/2019 13:24:45 answering member 4455 label Biography information for Seema Kennedy
tabling member	1516 label Biography information for Andy Slaughter

1125273

registered interest
date	08/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Heart Diseases: Death
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many deaths were caused by coronary heart disease in affected areas in England during the pollution episode in April 2019; and what comparative assessment he has made of the number of deaths attributed to heart disease in that period with the (a) expected average and (b) average over the last five years.
tabling member constituency	Hammersmith
tabling member printed	Andy Slaughter
uin	251939
answer	answer is ministerial correction date of answer 17/05/2019 answer text <p>According to the Daily Air Quality Index, there were ‘moderate’ to ‘very high’ levels of air pollution in some areas of the United Kingdom between 7 and 8 April 2019 and between 15 and 25 April 2019. The figures for deaths caused by coronary heart disease in this period are not available in the requested format and a comparative assessment has not been made.</p><p>In January 2019, the Government launched the Clean Air Strategy, which sets out plans for dealing with all sources of air pollution to save lives, protect nature and boost the economy.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 17/05/2019 13:22:33 answering member 4455 label Biography information for Seema Kennedy
tabling member	1516 label Biography information for Andy Slaughter

1124010

registered interest
date	30/04/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cervical Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to help ensure the approval of the use of Pembrolizumab for the treatment of cervical cancer given in line with its usage in the Republic of Ireland and the USA; and when that drug will be made available to people with cervical cancer.
tabling member constituency	Hammersmith
tabling member printed	Andy Slaughter
uin	249244
answer	answer is ministerial correction date of answer 07/05/2019 answer text <p>Pembrolizumab (Keytruda) was licensed on 12 June 2018 by the United States Food and Drug Administration for use in patients with recurrent or metastatic cervical cancer with disease progression on or after chemotherapy.</p><p>However, pembrolizumab is not licensed for the treatment of cervical cancer in the United Kingdom or in the European Union. To obtain a licence for this indication, the Marketing Authorisation Holder of Keytruda (Merck Sharp &amp; Dohme B.V.) would need to submit an ‘extension of indication’ application to the European Medicines Agency including evidence of safety and efficacy.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 07/05/2019 16:46:18 answering member 4455 label Biography information for Seema Kennedy
tabling member	1516 label Biography information for Andy Slaughter